Hemoptysis – cancer or pulmonary embolism? Review article
Article Sidebar
Main Article Content
Abstract
Oncological patients are a group at risk of venous thromboembolism. Hemoptysis may occur as an element of pulmonary embolism, as well as a result of malignancy. Hemoptysis always requires urgent and unequivocal diagnostic evaluation, but differentiation between cancer and pulmonary embolism is particularly important. Management is totally different and selection of the wrong option might have fatal consequences. The manuscript provides some hopefully useful suggestions of managing hemoptysis where oncology and cardiovascular diseases overlap.
Downloads
Metrics
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright: © Medical Education sp. z o.o. This is an Open Access article distributed under the terms of the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)
References
2. Hirshberg B., Biran I., Glazer M.: Hemoptysis: etiology, evaluation and outcome in a tertiary referral hospital. Chest 1997; 112: 440-444.
3. Santiago S., Tobias J., Williams A.J.: A reappraisal of the causes of hemoptysis. Arch. Intern. Med. 1991; 151: 2449-2451.
4. Hopwood P., Stephens R.J.: Symptoms at presentation for treatment in patients with lung cancer: implications for the evaluation of palliative treatment. The Medical Research Council (MRC) Lung Cancer Working Party. Br. J. Cancer 1995; 71(3): 633-636.
5. Lee A.Y., Levine M.N.: Venous thromboembolism and cancer: risks and outcomes. Circulation 2003 Jun 17; 107(23 Suppl 1): I17-21.
6. Torbicki A., Perrier A., Konstantinides S.: Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur. Heart J. 2008 Sep; 29(18): 2276-315.
7. Perrier A., Roy P.M., Aujesky D.: Diagnosing pulmonary embolism in outpatients with clinical assessment, D-dimer measurement, venous ultrasound, and helical computed tomography: a multicenter management study. Am. J. Med. 2004; 116: 291-299.
8. Kruip M.J., Slob M.J., Schijen J.H.: Use of a clinical decision rule in combination with D-dimer concentration in diagnostic workup of patients with suspected pulmonary embolism: a prospective management study. Arch. Intern. Med. 2002; 162: 1631-1635.
9. Di Nisio M., Sohne M., Kamphuisen P.W., Buller H.R.: D-Dimer test in cancer patients with suspected acute pulmonary embolism. J. Thromb. Haemost. 2005; 3: 1239-1242.
10. Righini M., Le Gal G., De Lucia S., Roy P.M., Meyer G., Aujesky D. et al.: Clinical usefulness of D-dimer testing in cancer patients with suspected pulmonary embolism. Thromb. Haemost. 2006; 95: 715-719.
11. Lee A.Y., Levine M.N., Baker R.I.: Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. Randomized Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer (CLOT) Investigators. N. Engl. J. Med. 2003 Jul 10; 349(2): 146-53.
12. Lee A.Y., Rickles F.R., Julian J.A.: Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism. J. Clin. Oncol. 2005 Apr 1; 23(10): 2123-9.
13. Douketis J., Berger P., Dunn A.: Antithrombotic therapy for venous thromboembolic disease. The Perioperative Management of Antithrombotic Therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest June 2008; 133(6 suppl): 299S-339S.
14. Spyropoulos A.C.: Bridging therapy and oral anticoagulation: current and future prospects. Curr. Opin. Hematol. 2010 Sep; 17(5): 444-9.
15. Wang G.R., Ensor J.E., Gupta S.: Bronchial artery embolization for the management of hemoptysisin oncology patients: utility and prognostic factors. J. Vasc. Interv. Radiol. 2009; 20(6): 722-729.
16. McCannon J., Temel J.: Comprehensive management of respiratory symptoms in patients with advanced lung cancer. J. Support. Oncol. 2012 Jan-Feb; 10(1): 1-9.